http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Gilead Sciences to Present at the Bernstein 31st Annual Strategic Decisions Conference on Thursday, May 28
-
Gilead Sciences to Present at the UBS 2015 Global Healthcare Conference on Tuesday, May 19
-
Gilead Sciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13
-
Gilead Sciences Acquires EpiTherapeutics
-
Gilead Sciences Declares First Quarterly Cash Dividend
-
Gilead Announces Results From Studies Evaluating Sofosbuvir-Based Regimens in Chronic Hepatitis C Patients With Genotypes 2-5
-
Gilead Sciences to Release First Quarter 2015 Financial Results on Thursday, April 30, 2015
-
Gilead’s Harvoni and Sovaldi Demonstrate Efficacy and Safety among Chronic Hepatitis C Patients with Advanced Liver Disease
-
Gilead Announces Data for Investigational, All-Oral, Pan-Genotypic Three-Drug Regimen of Sofosbuvir, GS-5816 and GS-9857 for Chronic Hepatitis C
-
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Emtricitabine/Tenofovir Alafenamide for HIV Treatment
-
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C
-
Gilead Sciences to Present at the Barclays Global Healthcare Conference on Wednesday, March 11
-
Streetinsider.com's Hot Lunchtime Reads 10/31: (LNKD) (GILD) (TWTR) (TSLA)
-
Gilead Sciences's (GILD) Harvoni RX 445 in Week One
-
UPDATE: Gilead Sciences (GILD) Hits Session Lows
-
Gilead Sciences (GILD): Traders Discuss Cheaper Version of Sovaldi
-
Griffin's Blue Ridge Capital Shows New Stakes in Allegion (ALLE), Castlight Health (CSLT), Myriad Genetics (MYGN), Walgreen (WAG) (more...)
-
Stocks Choppy With Escalation of Ukraine Violence
-
Stocks Sink; Margin Fears Take Center Stage
-
Blood-Bath in Nasdaq Stocks
-
Did Gilead (GILD) and Waxman Plan Meeting Ahead of Letter?
-
Stocks Weaker, Led by High-Beta Names
-
Blue Ridge Capital Enters Apple (AAPL), Twitter (TWTR) (more...)
-
Notable Analyst Rating Changes 01/08: (RAD) (PNRA) (FLIR) Upgraded; (AMBA) (TWTR) (TCS) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 12/02: (TWTR) (AMZN) (GILD) (TSLA)

